Reply to Coussement et al

Hannah Kaminski^{1

2}, Julie Belliere^{3

4}, Lionel Couzi^{1

2}, Nassim Kamar^{3

4

5}, Pierre Merville^{1

2}

Affiliations

¹ Department of Nephrology, Transplantation, Dialysis, and Apheresis, Pellegrin University Hospital, Bordeaux, France.
² CNRS UMR ImmunoConcEpT, Bordeaux University, Bordeaux, France.
³ Department of Nephrology and Organ Transplantation, CHU Toulouse, Toulouse, France.
⁴ Paul Sabatier University, Toulouse, France.
⁵ INSERM U1043, IFR-BMT, Toulouse, France.

Comment

Hannah Kaminski et al. Clin Infect Dis. 2021.

. 2021 Aug 16;73(4):753-754.

doi: 10.1093/cid/ciab022.

Hannah Kaminski^{1

2}, Julie Belliere^{3

4}, Lionel Couzi^{1

2}, Nassim Kamar^{3

4

5}, Pierre Merville^{1

2}

¹ Department of Nephrology, Transplantation, Dialysis, and Apheresis, Pellegrin University Hospital, Bordeaux, France.
² CNRS UMR ImmunoConcEpT, Bordeaux University, Bordeaux, France.
³ Department of Nephrology and Organ Transplantation, CHU Toulouse, Toulouse, France.
⁴ Paul Sabatier University, Toulouse, France.
⁵ INSERM U1043, IFR-BMT, Toulouse, France.

No abstract available

Comment on

Identification of Predictive Markers and Outcomes of Late-onset Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients.
Kaminski H, Belliere J, Burguet L, Del Bello A, Taton B, Poirot-Mazères S, Accoceberry I, Delhaes L, Visentin J, Gregori M, Iriart X, Charpentier E, Couzi L, Kamar N, Merville P. Kaminski H, et al. Clin Infect Dis. 2021 Oct 5;73(7):e1456-e1463. doi: 10.1093/cid/ciaa1611. Clin Infect Dis. 2021. PMID: 33095856
Pneumocystis jirovecii Pneumonia and Use of mTOR Inhibitors in Kidney Transplantation.
Coussement J, Manuel O. Coussement J, et al. Clin Infect Dis. 2021 Aug 16;73(4):752-753. doi: 10.1093/cid/ciab020. Clin Infect Dis. 2021. PMID: 33449997 No abstract available.